Crystals were harvested directly from LCP using 50150 m micromounts (M2-L19-50/150, MiTeGen), flash frozen, and stored in liquid nitrogen
And of all the systems where that combined coverage matters most, one stands apart, both in terms of the stakes involved and the specificity of the biological mechanisms at play
What UK law says The short version: none of these are licensed medicines in the UK, and supplying any of them for human use without a marketing authorisation is unlawful under the Human Medicines Regulations 2012
Metabolic Health Support GLP-1 therapy may help: Improve insulin sensitivity Support blood sugar regulation Improve metabolic function Reduce some risk factors associated with metabolic disease These effects are one reason these medications have become important tools in metabolic medicine
2026 guidance implies 22% topline growth and $715M adjusted EBITDA
I was on a webinar recently with someone who said, This is how companies can capitalize on GLP-1. I think thats the wrong approach